Breakthrough: Synthetic Protein Reverses Alzheimer’s Symptoms in Mice
OIST researchers develop groundbreaking nasal spray treatment showing promise in restoring memory and cognitive function In a major leap forward…
Category: Alzheimer’s
What Would a Donanemab Approval Mean for Leqembi?
Earlier this month, an FDA advisory committee determined that Eli Lilly’s anti-amyloid antibody donanemab is an effective treatment for Alzheimer’s disease and that its…
